n-methyl-3,4-methylenedioxyamphetamine has been researched along with Hepatitis C in 3 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CY | 1 |
Lin, KM | 1 |
O'Suilleabhain, P | 1 |
Giller, C | 1 |
White, B | 1 |
Day, C | 1 |
Degenhardt, L | 1 |
Kinner, S | 1 |
Fry, C | 1 |
Bruno, R | 1 |
Johnston, J | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Hepatitis C
Article | Year |
---|---|
Health consequences of illegal drug use.
Topics: Amphetamine; Depressive Disorder; Health Status; Hepatitis C; Humans; Illicit Drugs; Marijuana Abuse | 2009 |
2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Hepatitis C
Article | Year |
---|---|
Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
Topics: Adult; Antiparkinson Agents; Disease Progression; Hallucinogens; Hepatitis C; Humans; Indoles; Male; | 2003 |
Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
Topics: Adult; Amphetamine-Related Disorders; Australia; Comorbidity; Cross-Sectional Studies; Female; Hallu | 2006 |